Cue Biopharma Inc. (CUE)
1.21
-0.02 (-1.63%)
At close: Mar 03, 2025, 3:59 PM
1.20
-0.41%
After-hours: Mar 03, 2025, 04:00 PM EST
Cue Biopharma Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Net Income | -50.73M | -53.01M | -44.16M | -44.78M | -36.7M | -38.98M | -23.23M | -7.66M | -1.93M |
| Depreciation & Amortization | 3.44M | 1.81M | -1.78M | 1.06M | 5.17M | 760.01K | 419.57K | 202.09K | 44.81K |
| Stock-Based Compensation | 8.18M | 9.5M | 11.52M | 10.48M | 6.52M | 7.17M | 2.78M | 889.56K | n/a |
| Other Working Capital | -63K | -2.81M | -7.97M | -3.7M | 928.59K | 3.83M | 2.35M | 532.32K | -31.01K |
| Other Non-Cash Items | 90K | -453.78K | -26.13K | -563.23K | -4.28M | 345.1K | 4.93M | 65.91K | 79.55K |
| Deferred Income Tax | n/a | n/a | n/a | 83.69K | -18.19K | 79.86K | 10.68K | n/a | n/a |
| Change in Working Capital | -934K | 356.27K | -4.39M | 1.23M | -1.49M | 4.21M | 2.91M | 532.32K | 146.8K |
| Operating Cash Flow | -39.96M | -41.81M | -38.84M | -32.49M | -30.8M | -26.41M | -12.19M | -5.97M | -1.66M |
| Capital Expenditures | n/a | -170.75K | -913.04K | -595.26K | -46.35K | -1.85M | -1.2M | -515.98K | -754.29K |
| Acquisitions | n/a | 6.21K | 4.58K | 83.69K | 127.5K | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -29.45M | -4.58K | -9.95M | -15.13M | -39.5M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 25M | 5M | 10M | 15M | 18.5M | 21M | n/a | n/a | n/a |
| Other Investing Acitivies | 2K | -24.44M | 21.55K | -83.69K | 3.49M | -18.5M | -35 | -33 | -50K |
| Investing Cash Flow | 25M | -24.61M | 9.11M | 4.46M | 3.45M | -20.35M | -1.2M | -516.01K | -804.29K |
| Debt Repayment | -2M | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -271.05K | -91.03K | n/a | -4.16M | -1.41M | -1.14M |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 473K | 4.36M | 1.85M | 1.93M | 1.79M | 12.5K | 9.01K | n/a | 1K |
| Financial Cash Flow | 11.86M | 53.66M | 19.23M | 58.61M | 50.79M | 4.18M | 62M | 15.01M | 8.87M |
| Net Cash Flow | -3.1M | -12.76M | -10.5M | 30.58M | 23.44M | -42.58M | 48.61M | 8.52M | 6.41M |
| Free Cash Flow | -39.96M | -41.98M | -39.75M | -33.09M | -30.84M | -28.27M | -13.4M | -6.48M | -2.41M |